Clinical Trials
2 trialsNCT01094860 2020-02-11
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00005080 2013-01-16
506U78 in Treating Patients With Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed